Inventor · disambiguated record
Andreas Meinke
Also filed as: MEINKE ANDREAS
45 granted patents·26 pending applications·276 citations·filing 2001–2024
98Inventor score
Top patents by PatentIndex Score
71 records- 0193US11684669B2CpG-adjuvanted SARS-CoV-2 virus vaccineVALNEVA AUSTRIA GMBH·Filed 2021·Granted Jun 27, 2023·6 cites·30 claims
- 0293US11357846B2Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3VALNEVA SE·Filed 2021·Granted Jun 14, 2022·3 cites·17 claims
- 0393US11208439B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Dec 28, 2021·6 cites·19 claims
- 0493US9926343B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Mar 27, 2018·10 cites·18 claims
- 0592US12195501B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2021·Granted Jan 14, 2025·1 cites·23 claims
- 0692US8372411B2S. pneumoniae antigensINTERCELL AG·Filed 2009·Granted Feb 12, 2013·19 cites·30 claims
- 0792US7485710B2Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereofINTERCELL AG·Filed 2003·Granted Feb 3, 2009·43 cites·1 claims
- 0892US7438912B2S.agalactiae antigens I + IIINTERCELL AG·Filed 2004·Granted Oct 21, 2008·46 cites·7 claims
- 0991US12011477B2Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3VALNEVA SE·Filed 2022·Granted Jun 18, 2024·1 cites·22 claims
- 1091US11466058B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2019·Granted Oct 11, 2022·4 cites·10 claims
- 1191US10544194B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Jan 28, 2020·8 cites·9 claims
- 1291US7635487B2S. pneumoniae antigensINTERCELL AG·Filed 2004·Granted Dec 22, 2009·29 cites·16 claims
- 1389US8986704B2Mutant fragments of OspA and methods and uses relating theretoINTERCELL AUSTRIA AG·Filed 2013·Granted Mar 24, 2015·18 cites·12 claims
- 1489US7771728B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2006·Granted Aug 10, 2010·10 cites·13 claims
- 1587US11484587B2Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3VALNEVA SE·Filed 2018·Granted Nov 1, 2022·3 cites·19 claims
- 1686US8323660B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2010·Granted Dec 4, 2012·7 cites·6 claims
- 1784US12018054B2Multivalent OspA polypeptides and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Jun 25, 2024·3 cites·20 claims
- 1884US7960533B2Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereofINTERCELL AG·Filed 2009·Granted Jun 14, 2011·5 cites·16 claims
- 1983US7927607B2S. agalactiae antigens I and IIINTERCELL AG·Filed 2008·Granted Apr 19, 2011·5 cites·10 claims
- 2082US8449892B2S. agalactiae antigens I and IIMEINKE ANDREAS·Filed 2011·Granted May 28, 2013·5 cites·32 claims
- 2182US2023295245A1Mutant fragments of ospa and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 2281US8715688B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2012·Granted May 6, 2014·3 cites·16 claims
- 2380US12162909B2Subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2023·Granted Dec 10, 2024·0 cites·19 claims
- 2480US8715999B2Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccinesHEINZ FRANZ X·Filed 2009·Granted May 6, 2014·6 cites·34 claims
- 2579US8129165B2Borrelia antigensLUNDBERG URBAN·Filed 2007·Granted Mar 6, 2012·5 cites·8 claims
- 2678US12331084B2Multivalent OspA polypeptides and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2024·Granted Jun 17, 2025·0 cites·20 claims
- 2778US8303961B2Borrelia antigensLUNDBERG URBAN·Filed 2012·Granted Nov 6, 2012·3 cites·13 claims
- 2878US2025171501A1A subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2024·Application pending·0 cites
- 2977US7638136B2Streptococcus pyogene antigensINTERCELL AG·Filed 2004·Granted Dec 29, 2009·10 cites·16 claims
- 3076US8343510B2Protective proteins of S. agalactiae, combinations thereof and methods of using the sameINTERCELL AG·Filed 2008·Granted Jan 1, 2013·1 cites·15 claims
- 3174US8236325B2S. epidermidis antigensMEINKE ANDREAS·Filed 2009·Granted Aug 7, 2012·1 cites·16 claims
- 3274US7968297B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2002·Granted Jun 28, 2011·7 cites·16 claims
- 3373US8236326B2Klebsiella antigensBAKSHI SHARMILA·Filed 2008·Granted Aug 7, 2012·2 cites·11 claims
- 3472US8617574B2Nontypable Haemophilus influenzae antigensVON GABAIN ALEXANDER·Filed 2010·Granted Dec 31, 2013·4 cites·8 claims
- 3568US7628994B2S. epidermidis antigensINTERCELL AG·Filed 2004·Granted Dec 8, 2009·1 cites·9 claims
- 3666US2024358812A1Human metapneumovirus combination vaccineVALNEVA SE·Filed 2022·Application pending·0 cites
- 3766US2024181034A1Human metapneumo virus vaccineVALNEVA SE·Filed 2022·Application pending·0 cites
- 3865US12162907B2Subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2020·Granted Dec 10, 2024·0 cites·20 claims
- 3965US8349336B2Streptococcus pyogenes antigensINTERCELL AG·Filed 2009·Granted Jan 8, 2013·0 cites·15 claims
- 4065US8318908B2Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereofREINSCHEID DIETER J·Filed 2011·Granted Nov 27, 2012·1 cites·9 claims
- 4165US2025213667A1Clostridium difficile vaccineVALNEVA AUSTRIA GMBH·Filed 2023·Application pending·0 cites
- 4262US2015232517A1MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 4362US2010221277A1Chlamydia pneumoniae antigensMEINKE ANDREAS·Filed 2009·Application pending·0 cites
- 4462US2013122030A1S. epidermidis antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 4561US8241643B2Peptides protective against S. pneumoniae and compositions, methods and uses relating theretoMEINKE ANDREAS·Filed 2009·Granted Aug 14, 2012·0 cites·17 claims
- 4660US8952135B2S. agalactiae antigens I and IIVALNEVA AUSTRIA GMBH·Filed 2013·Granted Feb 10, 2015·0 cites·11 claims
- 4760US2014212448A1Klebsiella antigensVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 4858US8431128B2Enterococcus antigensMEINKE ANDREAS·Filed 2011·Granted Apr 30, 2013·0 cites·8 claims
- 4958US2006240029A1Chlamydia pneumoniae antigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 5058US2013287782A1Enterococcus antigensMEINKE ANDREAS·Filed 2013·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andreas Meinke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →